Mark Tepper, Ph.D.

Questioner
DISC Type : c

Board Chair at Eumentis Therapeutics Inc.

Greater Boston, United States

Overview

Mark Tepper is a serial biotech entrepreneur with a Ph. D. from Columbia University. He has a proven track record of founding innovative companies like Eumentis, Corbus, and Primatope, leading them from inception to successful exits. His expertise spans drug discovery and development across oncology, immunology, and neurodegenerative diseases.

After a distinguished 30-year career, Mark is now semi-retired and open to part-time board or advisory roles. He has several personal hobbies including SCUBA diving, fishing, boating, marine aquaria, beer making, and gardening. His entrepreneurial ventures even extended to aquaculture, having founded a company for shellfish production.

Unique fact: Beyond his extensive biopharma career, he founded and later sold Atlantic Aquaculture Technologies, a company that developed specialized vessels for producing oysters and clams.

Personality Overview

Systematic

Not Easily Convinced

Cautious & Analytical

They prefer to fully evaluate every situation.  They generally do not appreciate an overfriendly approach and prefer to stay to-the-point. While they don't hesitate to ask questions, they are generally risk-averse and tend to be late adopters.

Topics They Care About

Biotech Entrepreneurship
A serial founder with a track record of building and exiting multiple therapeutic companies, including Eumentis, Primatope (sold to Kiniksa), and Corbus Pharmaceuticals.
Neuroscience Therapeutics
As Founder of Eumentis Therapeutics, he is actively developing novel drugs for neurodevelopmental and neurodegenerative disorders like Alzheimer's, Autism, and Schizophrenia.
Drug Commercialization
His experience covers the full lifecycle from technology sourcing, fundraising, and business planning to taking two companies public and executing a trade sale.

Media Appearances

Mark has no verified media appearances

Work History

1-2025
Board Chair at Eumentis Therapeutics Inc.
8-2019 - 6-2025
Founder, President & CEO at Eumentis Therapeutics Inc.
5-2019 - 11-2024
Founder and Investor at Atlantic Aquaculture Technologies
4-2012 - 6-2019
Founder, CEO and Board Member at Primatope Therapeutics, Inc.
3-2019
Founder, President and CSO at Corbus Pharmaceuticals

Education

9-1980 - 1-1985
Ph.D. from Columbia University Vagelos College of Physicians and Surgeons
4-1985 - 4-1988
Postdoctoral Fellow from UMass Chan Medical School

More Information

Social Presence :

Prographics :

Exp : 13 Location : Greater Boston, United States Job Level : N/A Designation : Board Chair at Eumentis Therapeutics Inc.
URL has been copied!

Insights For Selling To Mark

During A Call Or A Meeting

DO's

  • If you have a lower priced product compared to the competition, call out the same
  • Emphasise more on facts and measurable benefits
  • Keep some extra margin in hand as they will likely negotiate the pricing

DONT's

  • Avoid rushing them, be polite and patient
  • Avoid phrases like ‘do not worry about’, ‘no one compares to’ etc.
  • Don’t overhype the product/pitch, keep it measured

When Cold Calling

When Writing An Email

While Negotiating & Closing

    The secret to closing fast with Mark is

  • Confidence that the product provides ROI, effective pricing and process adherence matter the most to them.

  • Will you ever get a clear answer from Mark

  • It doesn’t come naturally to them but they can say no if they are not convinced.

Insights For Deal Planning

    How fast (or slow) will Mark move?

  • They can move at a reasonable pace while making their decisions if they have the necessary information.

  • Can Mark take some risk or not?

  • If they believe that they have analyzed the situation well, they can take a little risk.

You And Mark

Personality Compatibility


More Profiles

Discover additional public profiles from our index.

Search more profiles

Looking for someone else? Search here for anyone.

Or visit Humantic AI to know more.